Oprelvekin Injectable Solution

Brand(s)
Neumega
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Wyeth Biopharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc. (2014-07-31)
Oldest Current Product
1997-11-01
License(s)
BLA
RxNORM
INJECTABLE SOLUTION\OPRELVEKIN

product(s) by strength(s)

oprelvekin 5 mg/ml injectable solution

original product(s)(s)

#idbrandcategorylabelerfirst marketedapplicationspl
1583940004NeumegaBLAWyeth Biopharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.1997-11-011036946408f6b7-8794-4dd5-2db6-0b44660c586d

application(s)

#idtitleapprovedtradenamesfda division
1103694oprelvekin Application1997-11-25NeumegaCDER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
16408f6b7-8794-4dd5-2db6-0b44660c586d (view SPL)NEUMEGA [nu-megprescriptionHuman PrescriptionWyeth Biopharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.ANALYSIS, API MANUFACTURE, LABEL, MANUFACTURE, PACK2014-07-316583940004

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII